Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1102/1470-7330.2012.9022 http://scihub22266oqcxt.onion/10.1102/1470-7330.2012.9022 C3460597!3460597 !23023233     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\23023233 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Cancer+Imaging 2012 ; 12 (2 ): 363-4 Nephropedia Template TP {{tp|p=23023233 |t=2012. Liver-specific contrast agents |pdf=|usr=}}{{23023233 }} gab.com Text Liver-specific contrast agents JO: Cancer Imaging http://www.kidney.de/pget.php?&tw=1&pmid=23023233 #FOAvip In the patient with cancer, magnetic resonance imaging is increasingly used as a diagnostic tool for disease detection, lesion characterization, as well as the assessment of treatment response. Although non-contrast T1-weighted and T2-weighted imaging, together with low molecular weight extracellular gadolinium contrast-enhanced T1-weighted magnetic resonance imaging remain the cornerstone for liver assessment, there is increasing recognition of the benefits of liver-specific contrast agents for disease evaluation. Twit Text FOAVip Liver-specific contrast agents ????Cancer Imaging http://www.kidney.de/pget.php?&tw=1&pmid=23023233 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=23023233 #FOAvip English Wikipedia <ref>{{Cite pmid|23023233 }}</ref> Liver-specific contrast agents #MMPMID23023233 Koh DM Cancer Imaging 2012[Sep]; 12 (2 ): 363-4 PMID23023233 show ga In the patient with cancer, magnetic resonance imaging is increasingly used as a diagnostic tool for disease detection, lesion characterization, as well as the assessment of treatment response. Although non-contrast T1-weighted and T2-weighted imaging, together with low molecular weight extracellular gadolinium contrast-enhanced T1-weighted magnetic resonance imaging remain the cornerstone for liver assessment, there is increasing recognition of the benefits of liver-specific contrast agents for disease evaluation. |*Contrast Media [MESH] |*Gadolinium DTPA [MESH] |*Organometallic Compounds [MESH] |Humans [MESH] |Liver Diseases/*diagnosis [MESH] |Liver/*pathology [MESH] |Magnetic Resonance Imaging/*methods [MESH]Liver-specific contrast agents (epmc).pdf DeepDyve Pubget Overpricing